SARS–CoV-2–specific T cell responses and correlations with COVID-19 patient predisposition
Open accessThe DOI matches its Crossref record; 54 of the 55 references it cites were found in a registry or an index.
Abstract
Coronavirus disease 2019 (COVID-19) has emerged as a global pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). So far, viral targets of cellular immunity and factors determining successful mounting of T cell responses are poorly defined. We therefore analyzed cellular responses to membrane, nucleocapsid, and spike proteins in individuals suffering from moderate or severe infection and in individuals who recovered from mild disease. We demonstrate that the CoV-2-specific CD4+ T helper cell response is directed against all 3 proteins with comparable magnitude, ex vivo proliferation, and portions of responding patients. However, individuals who died were more likely to have not mounted a cellular response to the proteins. Higher patient age and comorbidity index correlated with increased frequencies of CoV-2-specific CD4+ T cells, harboring higher portions of IL-2-secreting, but lower portions of IFN-γ-secreting, cells. Diminished frequencies of membrane protein-reactive IFN-γ+ T cells were particularly associated with higher acute physiology and chronic health evaluation II scores in patients admitted to intensive care. CoV-2-specific T cells exhibited elevated PD-1 expression in patients with active disease as compared with those individuals who recovered from previous mild disease. In summary, our data suggest a link between individual patient predisposition with respect to age and comorbidity and impairment of CoV-2-specific Th1-type cellular immunity, thereby supporting a concept of altered T cell function in at-risk patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“suggesting a link between individual patient predisposition with respect to age and comorbidity [127, 128].”
From Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) (2021) · cites this paper as [127]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263 · cited 1×
“Interestingly, both risk factors overlap with those identified to generally predict mortality in a recent retrospective study (22).”
BackgroundAPACHE II: A severity of disease classification system
KNAUS, W. A., DRAPER, E. A., WAGNER, D. P., & ZIMMERMAN, J. E. (1985) · Critical Care Medicine · doi:10.1097/00003246-198510000-00009 · Cited by 13,664
APACHE II-A Severity of Disease Classification System: Reply
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1986) · Critical Care Medicine · doi:10.1097/00003246-198608000-00028 · Cited by 13,376
Vincent, J. L., Moreno, R., Takala, J., Willatts, S., De Mendonça, A., Bruining, H., Reinhart, C. K., Suter, P. M., & Thijs, L. G. (1996) · Intensive Care Medicine · doi:10.1007/bf01709751 · Cited by 11,674
Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases
DEYO, R. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90133-8 · Cited by 10,452
Le Gall, J.-R. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.270.24.2957 · Cited by 7,773
APACHE II: a severity of disease classification system.
Knaus, W. A., Draper, E. S., Wagner, D. P., & Zimmerman, J. E. (1985) · PubMed · Cited by 6,034
Clinical and immunological features of severe and moderate coronavirus disease 2019
Chen, G., Wu, D., Guo, W., Cao, Y., Huang, D., Wang, H., Wang, T., Zhang, X., Chen, H., Yu, H., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137244 · Cited by 4,750 · cited 1×
“Consequently, 2 recent reports verified that patients with COVID-19 exhibit a trend toward lower frequencies IFN-γ+ cells after unspecific stimulation (20, 21), an observation that could be confirmed by using the polyclonal stimulus SEB.”
ResultA Prediction Rule to Identify Low-Risk Patients with Community-Acquired Pneumonia
Fine, M. J., Auble, T. E., Yealy, D. M., Hanusa, B. H., Weissfeld, L. A., Singer, D. E., Coley, C. M., Marrie, T. J., & Kapoor, W. N. (1997) · New England Journal of Medicine · doi:10.1056/nejm199701233360402 · Cited by 4,582
Grifoni, A., Weiskopf, D., Ramirez, S. I., Mateus, J., Dan, J. M., Moderbacher, C. R., Rawlings, S. A., Sutherland, A., Premkumar, L., Jadi, R. S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.015 · Cited by 3,595 · cited 1×
“So far, the contribution of Th cells to CoV-2–specific immunity is largely obscure, considering that only a few reports addressed specific T cell responses against multiple antigens (23, 24).”
BackgroundTo, K. K.-W., Tsang, O. T.-Y., Leung, W.-S., Tam, A. R., Wu, T.-C., Lung, D. C., Yip, C. C.-Y., Cai, J.-P., Chan, J. M.-C., Chik, T. S.-H., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30196-1 · Cited by 3,066 · cited 1×
“Although precise viral load was not routinely assessed in our patients, 2 recent reports indeed observed an elevated viral burden in patients with COVID-19 with advanced age (40) and/or severe disease (41), thereby supporting the notion of antigen load–dependent expansion of CoV-2–specific T cells.”
ResultReduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)
Diao, B., Wang, C., Tan, Y., Chen, X., Liu, Y., Ning, L., Chen, L., Li, M., Liu, Y., Wang, G., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00827 · Cited by 2,475 · cited 1×
“In that respect, Th and cytotoxic T cells show significantly higher ex vivo expression levels of PD-1 and TIM-3, suggesting a state of functional exhaustion (19).”
BackgroundCummings, M. J., Baldwin, M. R., Abrams, D., Jacobson, S. D., Meyer, B. J., Balough, E. M., Aaron, J. G., Claassen, J., Rabbani, L. E., Hastie, J., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31189-2 · Cited by 2,212 · cited 1×
“Factors determining clinical outcome include patient age, chronic pulmonary and heart disease, as well as excessive production of the inflammatory mediators interleukin 6 (IL-6) and 8 (IL-8) (3, 4).”
BackgroundImmunosuppression in Patients Who Die of Sepsis and Multiple Organ Failure
Boomer, J. S., To, K., Chang, K. C., Takasu, O., Osborne, D. F., Walton, A. H., Bricker, T. L., Jarman, S. D., Kreisel, D., Krupnick, A. S., et al. (2011) · JAMA · doi:10.1001/jama.2011.1829 · Cited by 1,781 · cited 1×
“An initial hyperinflammatory phase is also a hallmark of severe sepsis that is often followed by immunodepression, resulting, for example, in elevated PD-1 expression (34) along with reduced IFN-γ secretion by T cells (35), thus providing a possible link to our findings.”
ResultZheng, S., Fan, J., Yu, F., Feng, B., Lou, B., Zou, Q., Xie, G., Lin, S., Wang, R., Yang, X., et al. (2020) · BMJ · doi:10.1136/bmj.m1443 · Cited by 1,440 · cited 1×
“Although precise viral load was not routinely assessed in our patients, 2 recent reports indeed observed an elevated viral burden in patients with COVID-19 with advanced age (40) and/or severe disease (41), thereby supporting the notion of antigen load–dependent expansion of CoV-2–specific T cells.”
ResultAge and Age-Related Diseases: Role of Inflammation Triggers and Cytokines
Rea, I. M., Gibson, D. S., McGilligan, V., McNerlan, S. E., Alexander, H. D., & Ross, O. A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00586 · Cited by 1,267
Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans
Mateus, J., Grifoni, A., Tarke, A., Sidney, J., Ramirez, S. I., Dan, J. M., Burger, Z. C., Rawlings, S. A., Smith, D. M., Phillips, E., et al. (2020) · Science · doi:10.1126/science.abd3871 · Cited by 1,120
Ahmed, S. F., Quadeer, A. A., & McKay, M. R. (2020) · Viruses · doi:10.3390/v12030254 · Cited by 1,116
Grifoni, A., Sidney, J., Zhang, Y., Scheuermann, R. H., Peters, B., & Sette, A. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.03.002 · Cited by 940
SARS-CoV-2 infection protects against rechallenge in rhesus macaques
Chandrashekar, A., Liu, J., Martinot, A. J., McMahan, K., Mercado, N. B., Peter, L., Tostanoski, L. H., Yu, J., Maliga, Z., Nekorchuk, M., et al. (2020) · Science · doi:10.1126/science.abc4776 · Cited by 816
Betts, M. R., Ambrozak, D. R., Douek, D. C., Bonhoeffer, S., Brenchley, J. M., Casazza, J. P., Koup, R. A., & Picker, L. J. (2001) · Journal of Virology · doi:10.1128/jvi.75.24.11983-11991.2001 · Cited by 689 · cited 1×
“To identify SARS–CoV-2 reactive T cells, PBMCs were individually stimulated with overlapping peptide pools spanning membrane glycoprotein, nucleocapsid phosphoprotein, or spike glycoprotein with the capacity to activate both CD4+ and CD8+ T cells irrespective of HLA-type (16).”
MethodXu, J., Zhao, S., Teng, T., Abdalla, A. E., Zhu, W., Xie, L., Wang, Y., & Guo, X. (2020) · Viruses · doi:10.3390/v12020244 · Cited by 683
Jamilloux, Y., Henry, T., Belot, A., Viel, S., Fauter, M., El Jammal, T., Walzer, T., François, B., & Sève, P. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102567 · Cited by 658 · cited 1×
“Such interventions, including the evaluation of the PD-1/PD-1L pathway as a therapeutic target, are currently being controversially discussed (36, 37).”
BackgroundImpaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent
Mazzoni, A., Salvati, L., Maggi, L., Capone, M., Vanni, A., Spinicci, M., Mencarini, J., Caporale, R., Peruzzi, B., Antonelli, A., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci138554 · Cited by 502 · cited 2×
“Consequently, 2 recent reports verified that patients with COVID-19 exhibit a trend toward lower frequencies IFN-γ+ cells after unspecific stimulation (20, 21), an observation that could be confirmed by using the polyclonal stimulus SEB.”
BackgroundResultT Cell Responses to Whole SARS Coronavirus in Humans
Li, C. K.-F., Wu, H., Yan, H., Ma, S., Wang, L., Zhang, M., Tang, X., Temperton, N. J., Weiss, R. A., Brenchley, J. M., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.8.5490 · Cited by 497 · cited 1×
“T cell–mediated immunity against SARS-CoV 2002–03, exhibiting high homology to CoV-2 (6), has been shown to be preferentially directed against viral spike protein (7), which is also the target of potent neutralizing antibodies (8).”
BackgroundAirway Memory CD4+ T Cells Mediate Protective Immunity against Emerging Respiratory Coronaviruses
Zhao, J., Zhao, J., Mangalam, A. K., Channappanavar, R., Fett, C., Meyerholz, D. K., Agnihothram, S., Baric, R. S., David, C. S., & Perlman, S. (2016) · Immunity · doi:10.1016/j.immuni.2016.05.006 · Cited by 496 · cited 1×
“With respect to the precise role of cytokine secretion, a very recent study identified airway-resident, CoV nucleocapsid–specific Th cells as a critical source for IFN-γ production, since its neutralization was associated with significantly decreased survival after viral challenge (11).”
BackgroundChannappanavar, R., Fett, C., Zhao, J., Meyerholz, D. K., & Perlman, S. (2014) · Journal of Virology · doi:10.1128/jvi.01505-14 · Cited by 411
Chen, J., Lau, Y. F., Lamirande, E. W., Paddock, C. D., Bartlett, J. H., Zaki, S. R., & Subbarao, K. (2010) · Journal of Virology · doi:10.1128/jvi.01281-09 · Cited by 399
Single-cell transcriptomics reveals expansion of cytotoxic CD4 T cells in supercentenarians
Hashimoto, K., Kouno, T., Ikawa, T., Hayatsu, N., Miyajima, Y., Yabukami, H., Terooatea, T., Sasaki, T., Suzuki, T., Valentine, M., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1907883116 · Cited by 343 · cited 1×
“However, given that CoV-2 induces acute rather than long-lasting chronic infection, it is comprehensible that we did not detect typical T cell features associated with immunosenescence, such as downregulation of CD28, acquisition of granzyme B, or CD57 expression, being hallmarks of extremely long-lived individuals (2…”
BackgroundZhao, J., Zhao, J., & Perlman, S. (2010) · Journal of Virology · doi:10.1128/jvi.01049-10 · Cited by 340 · cited 1×
“The more detailed characterization of anti–SARS-CoV 2002–03–specific immunity proved that transfer of virus-specific CD4+ T cells into SCID mice mediated protection from lethal SARS-CoV challenge in the absence of humoral immunity (9).”
BackgroundBaruah, V., & Bose, S. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25698 · Cited by 268
Pourgheysari, B., Khan, N., Best, D., Bruton, R., Nayak, L., & Moss, P. A. H. (2007) · Journal of Virology · doi:10.1128/jvi.01262-06 · Cited by 214 · cited 1×
“, caused by persistent CMV infection) (30, 31).”
BackgroundControversies About COVID-19 and Anticancer Treatment with Immune Checkpoint Inhibitors
Bersanelli, M. (2020) · Immunotherapy · doi:10.2217/imt-2020-0067 · Cited by 213 · cited 1×
“Such interventions, including the evaluation of the PD-1/PD-1L pathway as a therapeutic target, are currently being controversially discussed (36, 37).”
BackgroundWu, J., Li, J., Zhu, G., Zhang, Y., Bi, Z., Yu, Y., Huang, B., Fu, S., Tan, Y., Sun, J., et al. (2020) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04160320 · Cited by 181 · cited 1×
“Factors determining clinical outcome include patient age, chronic pulmonary and heart disease, as well as excessive production of the inflammatory mediators interleukin 6 (IL-6) and 8 (IL-8) (3, 4).”
BackgroundDysfunctional CMV-specific CD8+ T cells accumulate in the elderly
Ouyang, Q., Wagner, W. M., Zheng, W., Wikby, A., Remarque, E. J., & Pawelec, G. (2004) · Experimental Gerontology · doi:10.1016/j.exger.2003.11.016 · Cited by 180
Dhanireddy, S., Altemeier, W. A., Matute‐Bello, G., O’Mahony, D. S., Glenny, R. W., Martin, T. R., & Liles, W. C. (2006) · Laboratory Investigation · doi:10.1038/labinvest.3700440 · Cited by 151
Bioinformatic prediction of potential T cell epitopes for SARS-Cov-2
Kiyotani, K., Toyoshima, Y., Nemoto, K., & Nakamura, Y. (2020) · Journal of Human Genetics · doi:10.1038/s10038-020-0771-5 · Cited by 145
Li, J., Gong, X., Wang, Z., Chen, R., Li, T., Zeng, D., & Li, M. (2020) · Virus Research · doi:10.1016/j.virusres.2020.198043 · Cited by 144 · cited 5×
“COVID-19 exhibits a diverse spectrum of clinical manifestations, ranging from a moderate course of infection with no or mild symptoms to viral pneumonia and hospitalization particularly in patients at risk, ultimately requiring intensive care unit (ICU) admission in case of acute respiratory distress syndrome (ARDS) (…”
BackgroundInfluentialAkondy, R. S., Johnson, P. L. F., Nakaya, H. I., Edupuganti, S., Mulligan, M. J., Lawson, B., Miller, J. D., Pulendran, B., Antia, R., & Ahmed, R. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1500475112 · Cited by 134 · cited 1×
“This relation has been verified in humans for live attenuated yellow fever vaccine, where viral load could be easily and repeatedly monitored in vaccinees’ plasma and correlated to specific cellular immunity (39).”
BackgroundT cells from patients with Candida sepsis display a suppressive immunophenotype
Spec, A., Shindo, Y., Burnham, C.-A. D., Wilson, S., Ablordeppey, E. A., Beiter, E. R., Chang, K., Drewry, A. M., & Hotchkiss, R. S. (2016) · Critical Care · doi:10.1186/s13054-016-1182-z · Cited by 128 · cited 1×
“An initial hyperinflammatory phase is also a hallmark of severe sepsis that is often followed by immunodepression, resulting, for example, in elevated PD-1 expression (34) along with reduced IFN-γ secretion by T cells (35), thus providing a possible link to our findings.”
ResultYang, L.-T., Peng, H., Zhu, Z.-L., Li, G., Huang, Z.-T., Zhao, Z.-X., Koup, R. A., Bailer, R. T., & Wu, C.-Y. (2006) · Clinical Immunology · doi:10.1016/j.clim.2006.05.002 · Cited by 117 · cited 1×
“3) membrane glycoprotein, nucleocapsid phosphoproeffector-type T cells for viral clearance, being accumulated in convalescent individuals and also making a contribution to the anti–SARS-CoV 2002–03 T cell response in recovered individuals (43).”
BackgroundKurth, F., Roennefarth, M., Thibeault, C., Corman, V. M., Müller-Redetzky, H., Mittermaier, M., Ruwwe-Glösenkamp, C., Heim, K. M., Krannich, A., Zvorc, S., et al. (2020) · Infection · doi:10.1007/s15010-020-01464-x · Cited by 100
Self-citationVentilator-induced endothelial activation and inflammation in the lung and distal organs
Hegeman, M. A., Hennus, M. P., Heijnen, C. J., Specht, P. A. C., Lachmann, B., Jansen, N. J. G., van Vught, A. J., & Cobelens, P. M. (2009) · Critical Care · doi:10.1186/cc8168 · Cited by 99 · cited 1×
“Innate inflammation as a driver for functional T cell exhaustion might also be fueled by mechanical ventilation (32) being applied to the majority of ICU patients included herein, since experimental data suggest an upregulation of IL-6 by this invasive treatment (33).”
BackgroundHulgan, T., Shepherd, B. E., Raffanti, S. P., Fusco, J. S., Beckerman, R., Barkanic, G., & Sterling, T. R. (2007) · The Journal of Infectious Diseases · doi:10.1086/510536 · Cited by 75
Porichis, F., Hart, M. G., Zupkosky, J., Barblu, L., Kwon, D. S., McMullen, A. M., Brennan, T., Ahmed, R., Freeman, G. J., Kavanagh, D. G., et al. (2013) · Journal of Virology · doi:10.1128/jvi.02034-13 · Cited by 73 · cited 1×
“Evidence from HIV-infected individuals suggests that IL-2 secretion as a cofactor for cellular expansion of specific T cells might be less sensitive to inhibition via the PD-1/PD-1L pathway, as opposed to IFN-γ secretion (42), permitting another explanation for the inverse correlation of IL-2 versus IFN-γ with patient…”
BackgroundReduced dynamic range of antiviral innate immune responses in aging
Molony, R. D., Malawista, A., & Montgomery, R. R. (2017) · Experimental Gerontology · doi:10.1016/j.exger.2017.08.019 · Cited by 69
The role of CD4+ T cells in BKV-specific T cell immunity
Weist, B. J. D., Schmueck‐Henneresse, M., Fuehrer, H., Sattler, A., Reinke, P., & Babel, N. (2014) · Medical Microbiology and Immunology · doi:10.1007/s00430-014-0348-z · Cited by 52
Self-citationThe Quantity of Autocrine IL-2 Governs the Expansion Potential of CD8+ T Cells
Redeker, A., Welten, S. P. M., Baert, M. R. M., Vloemans, S. A., Tiemessen, M. M., Staal, F. J. T., & Arens, R. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1501083 · Cited by 44 · cited 1×
“This relative cellular expansion might be mechanistically linked to an increased bioavailability of the T cell growth factor IL-2 perhaps acting in an autocrine fashion (38), since we uncover a positive correlation of IL-2+ M- and N-specific T cells with both risk factors.”
BackgroundJin, Y.-H., Hou, W., Kang, H. S., Koh, C.-S., & Kim, B. S. (2013) · Journal of Virology · doi:10.1128/jvi.01967-13 · Cited by 43 · cited 1×
“26), bearing, for example, the potential to enhance PD-1 expression on T cells (27), with subsequent implications for altered Th1 cytokine production.”
BackgroundThe TCR V signature of bacterial superantigens spreads with stimulus strength
Llewelyn, M. (2006) · International Immunology · doi:10.1093/intimm/dxl076 · Cited by 39
Predicting AIDS-related events using CD4 percentage or CD4 absolute counts
Pirzada, Y., Khuder, S., & Donabedian, H. (2006) · AIDS Research and Therapy · doi:10.1186/1742-6405-3-20 · Cited by 34 · cited 1×
“Although ICU- and non-ICU patients showed similar absolute CD4+ T cell counts within 3 days around the date of our relative quantifications, a side-by-side comparison of both measures, such as has been extensively performed in HIV infection, has the potential to identify patient subgroups (45, 46).”
BackgroundLi, Q., Zhang, J., Ling, Y., Li, W., Zhang, X., Lu, H., & Chen, L. (2020) · Infection · doi:10.1007/s15010-020-01446-z · Cited by 30
Hassouneh, F., López-Sejas, N., Campos, C., Sánchez-Correa, B., Tarazona, R., Solana, R., & Pera, A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00649 · Cited by 28 · cited 1×
“, caused by persistent CMV infection) (30, 31).”
Background
Cited by
Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant
Madhi, S. A., Baillie, V., Cutland, C. L., Voysey, M., Koen, A. L., Fairlie, L., Padayachee, S. D., Dheda, K., Barnabas, S. L., Bhorat, Q. E., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2102214 · Cited by 1,257
Madhi, S. A., Baillie, V., Cutland, C. L., Voysey, M., Koen, A. L., Fairlie, L., Padayachee, S. D., Dheda, K., Barnabas, S. L., Bhorat, Q. E., et al. (2021) · doi:10.1101/2021.02.10.21251247 · Cited by 1,257
Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)
Cossarizza, A., Chang, H., Radbruch, A., Abrignani, S., Addo, R., Akdis, M., Andrä, I., Andreata, F., Annunziato, F., Arranz, E., et al. (2021) · European Journal of Immunology · doi:10.1002/eji.202170126 · Cited by 531
Ferretti, A. P., Kula, T., Wang, Y., Nguyen, D. M. V., Weinheimer, A., Dunlap, G. S., Xu, Q., Nabilsi, N., Perullo, C. R., Cristofaro, A. W., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.10.006 · Cited by 318
Immunological memory to SARS‐CoV‐2 infection and COVID‐19 vaccines
Sette, A., & Crotty, S. (2022) · Immunological Reviews · doi:10.1111/imr.13089 · Cited by 269
“Pre-existing comorbidities in COVID patients have been reported to affect magnitude and helper T cell subset composition 128 .”
Metadata
- Authors
- Sattler, A., Angermair, S., Stockmann, H., Heim, K. M., Khadzhynov, D., Treskatsch, S., Halleck, F., Kreis, M. E., & Kotsch, K.
- Corresponding author
- Sattler, Arne
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2020-11-03
- Volume
- 130
- Issue
- 12
- Pages
- 6477-6489
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC7685725
- OpenAlex
- W3080524815
- Cited by
- 196
- References
- 55
- Citations by year
- 2026: 4 · 2025: 11 · 2024: 14 · 2023: 25 · 2022: 52 · 2021: 80 · 2020: 10
- FWCI
- 5.48
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Sonnenfeldstiftung (FACS facility support)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- SARS-CoV-2, COVID-19 pandemic, T cell response, CD4+ T helper cells, cell-mediated immunity, membrane proteins, nucleocapsid protein, spike protein, Th1 response, PD-1, interleukin-2, interferon-gamma, age, comorbidities, APACHE II score, mortality, intensive care, disease severity
- MeSH terms
- COVID-19, SARS-CoV-2, Adult, Age Factors, Aged, Aged, 80 and over, Disease Susceptibility, Female, Humans, Interferon-gamma, Interleukin-2, Male, Middle Aged, Severity of Illness Index, Th1 Cells, Programmed Cell Death 1 Receptor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.